Health & Wellness
MyGenome Earns ISO 15189 Accreditation for Whole Genome Sequencing
The accreditation signals growing regulatory rigor around nutrigenomic and precision-nutrition testing services in the …
All 622 stories
Industry & Business
Editorial Note: Submitted Release Outside Functional News Coverage Scope
Functional News covers functional foods, nutraceuticals, dietary supplements, and ingredient innovation. This release d…
Science & Research
LNS8801 Enters NIA Interventions Testing Program for Longevity Research
Dual selection by NIA ITP and ARPA-H PROSPR signals growing institutional validation for longevity-targeting compounds …
Regulatory & Policy
Isupartob Sodium Earns FDA Fast Track for Sepsis Indication
Fast Track status enables rolling review and closer FDA collaboration — a potential signal for future nutraceutical-adj…
Ingredients & Formulation
Intranasal Ondansetron Shows IV-Comparable PK in Preclinical Study
The intranasal delivery route could expand non-injectable antiemetic options; human PK data expected by late 2026.
Science & Research
Actuate Therapeutics' Elraglusib Enters Pediatric Oncology Platform Trial
The GSK-3β inhibitor joins a Cancer Research UK-sponsored multi-arm trial after a complete response was recorded in a p…
Functional Foods & Beverages
GURU Organic Energy Lands Sprouts Farmers Market Nationwide Listing
The placement positions GURU inside one of the natural channel's highest-engagement retail environments as functional e…
Functional Foods & Beverages
GURU Organic Energy Enters Sprouts Farmers Market Nationally
The Canadian organic energy brand gains a direct shelf position in one of natural retail's highest-engagement banners a…
Health & Wellness
Gotta Habit Wraps Launch at $5 Price Point Amid QSR Inflation
With average QSR lunch tickets pushing $15–$20, value-positioned functional wraps are carving a new lane in the better-…
Condition-Specific Health
BrainsWay SWIFT Deep TMS Posts 80% Remission Rate at 12 Months
Preliminary durability data presented at the Clinical TMS Society Annual Meeting signal a potential shift in how device…
Condition-Specific Health
TG Therapeutics SC BRIUMVI Shows 82% MCID Rate in Myasthenia Gravis Phase 1
TG Therapeutics advances to a potential registration-directed Phase 2 trial as subcutaneous delivery format targets imp…
Condition-Specific Health
Invivyd Launches Phase 3 Trial for VYD2311 mAb COVID Prevention
Topline data from the randomized, double-blind LIBERTY study is expected in Q3 2026, alongside results from the pivotal…